https://www.selleckchem.com/sc....reening/fda-approved
6%), osteoporosis (+ 10.9%) and cancer (+ 10.3%). Compared to the general population and after age and sex adjustment, participants had a significantly higher prevalence for 14/19 comorbidities at the time of study. The associations were strongest for anaemia, cancer (both PR 4.0, anxiety, depression, migraine (all PR 3.0, psoriasis and epilepsy (both PR 2.0. No significant differences were seen by onset type. Comorbidities are common at MS symptom onset and increase with MS duration. Having MS ma
Like
Comment
Share
